Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-959-5 | CAS number: 22398-80-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An acute oral toxicity study was performed on Indium Phosphide according to a method similar to the OECD TG 420.
Four-week-old Male ICR mice (SPF grade) were given a single dose of 0, 1,000, 3,000 or 5,000 mg/kg bw of Indium Phosphide (99.999% Purity) as a powder in physiological saline solution.
Following the exposure observations of behaviour, body weight and external appearance were made for two weeks. Ensuing the observation period, the mice were sacrificed and their blood was collected for analysis, and their kidneys, lungs, spleen, liver and testes were all observed and weighed. Indium concentrations observed in organs were compared to those of the control and higher dose groups.
No mice died due to oral exposure to Indium Phosphide. No changes in external appearance, behaviour and body weights among the groups were observed. Traces of indium phosphide were detected in the serum, liver and kidneys, however no clear increases of the weight of these organs were recorded. A decrease of the blood urea nitrogen proportionate to the increased exposure concentration was noted. Finally, colour change on the lung surface of numerous mice were observed.
Considering that Indium Phosphide has a LD50 > 5,000 mg/kg bw, it does not meet the criteria for classification according to Regulation 1272/2008.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1996
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- yes
- Remarks:
- highested dose investigated and number of animals used not in accordance with OECD TG 420.
- GLP compliance:
- no
- Test type:
- fixed dose procedure
- Limit test:
- no
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Nippon SLC
- Age at study initiation: 4 weeks
- Weight at study initiation: Not reported
- Fasting period before study: No
- Housing: Plastic cage
- Diet : Pelleted rodent chow (ad libitum)
- Water: Distilled water (ad libitum)
- Acclimation period: 1 week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 24
- Humidity (%): 60%
- Air changes (per hr): Not reported
- Photoperiod (hrs dark / hrs light): 12hrs dark/12hrs light - Route of administration:
- oral: unspecified
- Vehicle:
- physiological saline
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0, 1,000, 3,000, or 5,000 mg/kg of InP particles suspended in 0.3 ml of physiological
MAXIMUM DOSE VOLUME APPLIED: 5,000 mg/kg - Doses:
- 0, 1,000, 3,000, or 5,000mg/kg
- No. of animals per sex per dose:
- 3 males at 0 mg/kg, 9 males at 1,000 mg/kg, 9 males at 3,000 mg/kg and 6 males at 5,000 mg/kg.
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Behaviour and external apperance every weekday. Bodyweight every other day.
- Necropsy of survivors performed: yes
- Other examinations performed: The lungs, liver,kidneys, spleen, and testes were carefully observed, removed and weighed. Additionally blood analysis and serum indium concentrations were measured. - Statistics:
- Student's t- test or Welch's method were used to establish the difference between the means of the effect indices. Fischer's test was used for the analysis of pathological findings.
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No Mice died during the two week observation period.
- Clinical signs:
- other: No clear changes in behaviour or external apperance were found.
- Gross pathology:
- Colour change of the lung surface observed.
- Other findings:
- - Organ weights: There was no clear tendency in increase of the lung, spleen or kidney weight
- Potential target organs: Lungs
- Other observations: Traces of Indium phosphide detected in the serum, kidneys and liver. Blood urea nitrogen decreased proportionate to the increase in exposure concentration. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Following an acute oral toxicity experiment in mice, it was determined that Indium Phosphide was not acutely toxic via the oral route under the conditions of the study. No mortality was observed at the highest dose over a 14-day period, rendering an LD50 > 5,000 mg/kg bw. The substance does not meet the criteria for classification according to Regulation 1272/2008.
- Executive summary:
An acute oral toxicity study was performed on Indium Phosphide according to a method similar to the OECD TG 420.
Four-week-old Male ICR mice (SPF grade) were given a single dose of 0, 1,000, 3,000 or 5,000 mg/kg bw of Indium Phosphide (99.999% Purity) as a powder in physiological saline solution.
Following the exposure observations of behaviour, body weight and external appearance were made for two weeks. Ensuing the observation period, the mice were sacrificed and their blood was collected for analysis, and their kidneys, lungs, spleen, liver and testes were all observed and weighed. Indium concentrations observed in organs were compared to those of the control and higher dose groups.
No mice died due to oral exposure to Indium Phosphide. No changes in external appearance, behaviour and body weights among the groups were observed. Traces of indium phosphide were detected in the serum, liver and kidneys, however no clear increases of the weight of these organs were recorded. A decrease of the blood urea nitrogen proportionate to the increased exposure concentration was noted. Finally, colour change on the lung surface of numerous mice were observed.
Considering that Indium Phosphide has a LD50 > 5,000 mg/kg bw, it does not meet the criteria for classification according to Regulation 1272/2008.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- The acute toxicity of Indium Phosphide via the oral route was evaluated using a method similar to OECD guideline 420 (Fixed dose procedure) without any significant deviations.
Additional information
Justification for classification or non-classification
This study determined the LDL0 of indium phosphide following oral administration to male mice to be >5,000mg/kg. The LD50 could not be calculated in this study therefore based on these results, it can be concluded that the LD50 of indium phosphide is >5000mg/kg and therefore the substance will be classified as a GHS category 5 substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.